Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Perrigo
Sort By
Newest First
Sign in
1 / 1
1 / 1
FDA Approval
Perrigo and Catalent Announce FDA Approval of Perrigo's AB-Rated Generic Version of ProAir® HFA
Perrigo
PR-M02-20-NI-041
Feb 27, 2020
Finance
Perrigo Increases Its Dividend By 11%
Perrigo
PR-M04-19-NI-090
Apr 30, 2019
ANDA
Perrigo Confirms Patent Challenge for Generic Version of Nascobal®
Nice Insight
PR-M03-19-NI-020
Mar 07, 2019
Milestone Payment
Perrigo To Receive Milestone Payment Of $250 Million From RPI Finance Trust
Perrigo
PR-M01-19-NI-095
Feb 01, 2019
Appointment
Perrigo Appoints James Dillard To Role Of Chief Scientific Officer
Perrigo
PR-M01-19-NI-044-3142
Jan 16, 2019
FDA Approval
Perrigo Announces Tentative FDA Approval for the First To file Generic Version Of Ultravate® Lotion 0.05%
Perrigo
PR-M11-18-NI-107
Nov 30, 2018
Launch
Perrigo Launches Its AB Rated Generic Version of Solaraze® Gel 3%
Perrigo
PR-M11-18-NI-100-3329
Nov 28, 2018
Patent
Perrigo Confirms Patent Challenge For Generic Version Of Kerydin®
Perrigo
PR-M11-18-NI-008
Nov 02, 2018
Financial Results
Perrigo To Release Third Quarter Calendar Year 2018 Financial Results On November 8, 2018
Perrigo
PR-M10-18-NI-097
Oct 29, 2018
Growth Strategy
Perrigo Expands OTC Growth Strategy With Rx-To-OTC Switch Licensing For Nasonex®
Perrigo
PR-M08-18-NI-117
Aug 30, 2018
Business
Perrigo to Divest Its Prescription Drug Business
Nice Insight
PAO-M08-18-NI-015
Aug 14, 2018
Launch
Perrigo Launches Novel Omeprazole Orally Disintegrating Tablet to Treat Frequent Heartburn
Perrigo
PR-M04-18-NI-50
Apr 16, 2018
FDA
Perrigo Announces Final FDA Approval and Planned Launch for the Store Brand OTC Equivalent of Mucinex® DM Maximum Strength Extended Release Tablets
Perrigo
PR-M03-18-NI-037-4609
Mar 09, 2018
Appointment
Perrigo Appoints Ronald L. Winowiecki as Chief Financial Officer
Perrigo
PR-M02-18-NI-89
Feb 23, 2018
Generics
Perrigo Confirms Patent Challenge For Generic Version Of Finacea® Foam, 15%
Perrigo
PR-M02-18-NI-90
Feb 23, 2018
Acquisition
Perrigo Sells API Business to SK Capital
Nice Insight
PAO-M08-17-NI-033
Aug 25, 2017
